SCHEMBL24814740

SCHEMBL24814740

O=C(CS(=O)(=O)c1nccs1)N1Cc2cc(F)c(F)cc2C1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NLRP3 Q96P20 1/20 0.35
▸ NAMPT P43490 1/20 0.32
▸ ACP1 P24666 1/20 0.32
▸ GRM4 Q14833 1/20 0.31
▸ CTSL P07711 1/20 0.31
▸ CTSB P07858 1/20 0.31
▸ CTSS P25774 1/20 0.31
▸ CTSK P43235 1/20 0.31
▸ SCN3A Q9NY46 1/20 0.31
▸ HCRTR2 O43614 1/20 0.31
▸ KAT8 Q9H7Z6 1/20 0.31
▸ DPP8 Q6V1X1 1/20 0.30
▸ DPP9 Q86TI2 1/20 0.30
▸ NPC1 O15118 1/20 0.30
▸ CYP1A2 P05177 1/20 0.30
▸ CYP3A4 P08684 1/20 0.30
▸ CYP2D6 P10635 1/20 0.30
▸ CYP2C9 P11712 1/20 0.30
▸ CYP2C19 P33261 1/20 0.30
▸ RAB9A P51151 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24817122 0.88 NAMPT (0.44) NAMPTDPP8DPP9
SCHEMBL24815670 0.88 NLRP3 (0.35) NLRP3ACP1HCRTR2KAT8NPC1
SCHEMBL24815669 0.85 SMN1; SMN2 (0.42) NAMPTNPC1CYP1A2CYP3A4CYP2D6
SCHEMBL29986905 0.85 SMN1; SMN2 (0.42) NAMPTNPC1CYP1A2CYP3A4CYP2D6
SCHEMBL29987551 0.84 MAOB (0.39) NLRP3NAMPTSMN1; SMN2
SCHEMBL29986896 0.84 DPP8 (0.41) NAMPTDPP8DPP9NPC1CYP1A2
SCHEMBL24814392 0.84 DPP8 (0.41) NAMPTDPP8DPP9NPC1CYP1A2
SCHEMBL26845908 0.83 DPP8 (0.40) NAMPTDPP8DPP9SMN1; SMN2
SCHEMBL24817127 0.83 MAOB (0.40) NAMPTSCN3ASMN1; SMN2
SCHEMBL24814391 0.82 RYR2 (0.43) NAMPTCYP1A2CYP3A4CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11827629-B2 CDGSH iron sulfur domain 2 activators and use thereof NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2023-11-28 — — US disclosed
US-11827629-B2 CDGSH iron sulfur domain 2 activators and use thereof NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2023-11-28 — — US disclosed
US-20220411418-A1 CDGSH IRON SULFUR DOMAIN 2 ACTIVATORS AND USE THEREOF NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2022-12-29 — — US disclosed
WO-2022251343-A2 CDGSH IRON SULFUR DOMAIN 2 ACTIVATORS AND USE THEREOF NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2022-12-01 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220411418-A1 CDGSH IRON SULFUR DOMAIN 2 ACTIVATORS AND USE THEREOF CISD2, CISD1, FECH NLRP3 3821/4885NAMPT 2850/4885ACP1 4267/4885
US-11827629-B2 CDGSH iron sulfur domain 2 activators and use thereof CISD2, CISD1, FECH NLRP3 3821/4885NAMPT 2850/4885ACP1 4267/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback